1. Centers for Disease Control and Prevention. Overweight and obesity: adult obesity facts, https://www.cdc.gov/obesity/data/adult.html (2022, accessed 23 November 2023).
2. Food and Drug Administration (FDA). FDA approves new drug treatment for chronic weight management, first since 2014, https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014. (2021, accessed 23 November 2023).
3. Food and Drug Administration (FDA). FDA Approves new medication for chronic weight management, https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management (2023, accessed 10 December 2023).
4. Collins L, Costello RA. Glucagon-like peptide-1 receptor agonists. Updated January 13, 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK551568/ (2023, accessed 23 November 2023).
5. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity